Neurovax
/ CORRECTION - EQUITIES Magazine
Market Wire (press release) - USA
... It offers NeuroVax, which is based on T-cell receptor peptide technology for the treatment of multiple sclerosis; and IR103 and Remune for the treatment of ...
posted by Bill at 1:33 AM
0 Comments:
Post a Comment
<< Home